MARKET

MRUS

MRUS

Merus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.55
+0.18
+1.10%
Opening 10:03 10/23 EDT
OPEN
16.50
PREV CLOSE
16.37
HIGH
16.90
LOW
16.39
VOLUME
7.33K
TURNOVER
--
52 WEEK HIGH
20.95
52 WEEK LOW
11.00
MARKET CAP
387.16M
P/E (TTM)
-11.5162
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MRUS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MRUS News

  • We Think Merus (NASDAQ:MRUS) Can Afford To Drive Business Growth
  • Simply Wall St..09/20 14:42
  • 46 Biggest Movers From Yesterday
  • Benzinga.09/20 08:45
  • Merus reports Q2 results
  • seekingalpha.08/20 01:05
  • Merus N.V. (MRUS) Reports Q2 Loss, Misses Revenue Estimates
  • Zacks.08/19 22:15

More

Industry

Biotechnology & Medical Research
-0.26%
Pharmaceuticals & Medical Research
-0.04%

Hot Stocks

Name
Price
%Change

About MRUS

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.
More

Webull offers Merus NV (MRUS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.